Trial intelligence / Profile preview

Atorvastatin for GVHD Prophylaxis in HSCT

NCT01665677Phase 2Completed

Start
Jan 2014
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atorvastatin in graft-versus-host disease (GVHD). Started Jan 2014; status: completed.

02

Drugs

atorvastatin
03

Conditions

graft-versus-host disease (GVHD)

Beyond the preview

Go deeper on NCT01665677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01665677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call